Microparticle therapy shows promise in reversing multiple sclerosis
A pioneering study demonstrated a novel microparticle therapy's ability to reverse nerve cell damage caused by multiple sclerosis (MS) in mice. This ground-breaking medication not only opens up new avenues for treating MS, but it also has promise for treating other autoimmune diseases such as Read More...
Study brings us one step closer to sustainable pharmaceuticals
On average, the pharmaceutical industry creates 100kg of waste for every 1kg of small-molecule drug synthesized, which creates a lot of toxic waste. Furthermore, nitrogen-containing chemicals called primary amines, which are used in the majority of all pharmaceuticals, are sought after in the Read More...
We are one step closer to finding an effective treatment for MS
Scientists at the University of Cambridge have a taken key step in finding a treatment for multiple sclerosis (MS). In a clinical trial of the cancer drug bexarotene, it was found that the drug repairs the protective myelin coatings around nerves that are damaged by the disease. The only issue Read More...
Multiple sclerosis linked to food poisoning bug
The causes of multiple sclerosis (MS) have remained unclear despite decades of research. But new findings have linked this debilitating disease to a toxin produced by some strains of the bacteria that causes food poisoning. Based on their findings in mice and MS patients, the investigators believe Read More...